SIX · BSLN.SW
Basilea Pharmaceutica AG
CHF 71.20-CHF 0.30 (-0.42%)
Basilea Pharmaceutica AG’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
Loading market information…
OTC · TRXPF · USD
Stock price, dividends, earnings
Quote as of Aug 26, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Torii Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Torii Pharmaceutical Co., Ltd.’s forward annual dividend is $0.84 per share, paid semi-annual. The forward yield is 3.43% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Torii Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Torii Pharmaceutical Co., Ltd., a Tokyo-based Japanese firm established in 1872, specializes in the development and commercialization of a variety of pharmaceutical products. Its therapeutic portfolio features Riona, a medication addressing hyperphosphatemia, and REMITCH, an oral treatment for pruritus commonly experienced by patients undergoing dialysis or suffering from liver diseases. The company also produces ANTEBATE, a topical solution for skin ailments such as atopic and contact dermatitis, which functions by reducing inflammation. Furthermore, Torii Pharmaceutical provides allergen immunotherapy tablets, specifically CEDARCURE and MITICURE, in addition to CORECTIM, a topical janus kinase (JAK) inhibitor. The company's products are primarily promoted to healthcare professionals through its team of medical representatives. Originally named Torii Shoten K.K., the organization officially became Torii Pharmaceutical Co., Ltd. in May 1949, and it operates today as a subsidiary of Japan Tobacco Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:36 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 71.20-CHF 0.30 (-0.42%)
Basilea Pharmaceutica AG’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
$0.55$0.00 (0.0%)
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
€18.65-€0.05 (-0.27%)
Boiron S.A.’s quoted price sits in the lower half of its reported 52-week range, 42.17% below the high.
HK$1.25-HK$0.03 (-1.96%)
Viva Biotech Holdings’s quoted price sits in the lower half of its reported 52-week range, 56.29% below the high.
£0.04-£0.00 (-6.25%)
Allergy Therapeutics plc’s quoted price sits in the lower half of its reported 52-week range, 69.01% below the high.
SEK 19.00-SEK 0.14 (-0.73%)
Swedencare AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 52.32% below the high.
$0.23+$0.00 (+0.55%)
Elite Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.78% below the high.
€0.54-€0.01 (-1.09%)
AB Science S.A.’s quoted price sits in the lower half of its reported 52-week range, 66.34% below the high.
